Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (DFPH) Other Non-Current Liabilities (2020 - 2025)

Historic Other Non-Current Liabilities for Oncology Institute (DFPH) over the last 6 years, with Q3 2025 value amounting to $13.7 million.

  • Oncology Institute's Other Non-Current Liabilities rose 255719.84% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year increase of 255719.84%. This contributed to the annual value of $385000.0 for FY2024, which is 8750.81% down from last year.
  • According to the latest figures from Q3 2025, Oncology Institute's Other Non-Current Liabilities is $13.7 million, which was up 255719.84% from $7.7 million recorded in Q2 2025.
  • In the past 5 years, Oncology Institute's Other Non-Current Liabilities ranged from a high of $20.6 million in Q1 2022 and a low of $385000.0 during Q4 2024
  • Over the past 5 years, Oncology Institute's median Other Non-Current Liabilities value was $4.0 million (recorded in 2022), while the average stood at $6.1 million.
  • As far as peak fluctuations go, Oncology Institute's Other Non-Current Liabilities tumbled by 9628.24% in 2023, and later soared by 255719.84% in 2025.
  • Over the past 5 years, Oncology Institute's Other Non-Current Liabilities (Quarter) stood at $6.9 million in 2021, then plummeted by 42.61% to $4.0 million in 2022, then decreased by 22.17% to $3.1 million in 2023, then crashed by 87.51% to $385000.0 in 2024, then surged by 3447.53% to $13.7 million in 2025.
  • Its last three reported values are $13.7 million in Q3 2025, $7.7 million for Q2 2025, and $3.7 million during Q1 2025.